Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Viale, Giuseppe; Giobbie-Hurder, Anita; Regan, Meredith; Coates, Alan; Mastropasqua, Mauro; Dell'Orto, Patrizia; Maiorano, Eugenio; MacGrogan, Gaetan; Braye, Stephen; Oehlschlegel, Christian; Neven, Patrick; Orosz, Zsolt; Olszewski, Wojciech; Knox, Fiona; Thuerlimann, Beat; Price, Karen; Castiglione-Gertsch, Monica; Gelber, Richard; Gusterson, Barry; Goldhirsch, Aron

doi:10.1200/jco.2008.17.0829

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Copy For Citation

Viale G., Giobbie-Hurder A., Regan M. M., Coates A. S., Mastropasqua M. G., Dell'Orto P., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.26, no.34, pp.5569-5575, 2008 (SCI-Expanded)

Publication Type: Article / Article
Volume: 26 Issue: 34
Publication Date: 2008
Doi Number: 10.1200/jco.2008.17.0829
Journal Name: JOURNAL OF CLINICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.5569-5575
Istanbul University Affiliated: No

Abstract

Purpose To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer.